1Pruneri G, Bertolini F, Soligo D et al. Angiogenesis in myelodysplastic syndromes. Br J Cancer. 1999.81 : 1398-1401.
2Padro T, Ruiz S, Bieker R, et al. Increased angiogenesis in the bone marrow of patients with acute myeloid leukemia. Blood, 2000,95 : 2637 - 2644.
3Aguayo A, Kantarjion H, Manshouri T. et al. Angiogenesis in acute and chronic leukemias and myelodysplastic syndromes. Blood, 2000,96 : 2240- 2245.
同被引文献6
1Dietz A, Rudat V, Conradt C, et al. Prognostic relevance of serum levels of the angiogenic peptide bFGF in advanced carcinoma of the head and neck treated by primary radiochemotherapy. Head neck, 2000, 22:666-673.
2Obermair A, Speriser P, Reisenberger K, et al. Influence of intratumoral basic fibroblast growth factor concentration on survival in ovarian cancer patients. Cancer Lett, 1998, 130:69-76.
3Hanahan D, Folk man J. Patterns and emerging mechanisms of the angiogenic switch during tumorigenesis.Cell, 1996, 86:353-364.
4Dow J K, White R W. Fibroblast Growth Factor 2: Its Structure and Property, Paracrine Function, Tumor Angiogenesis, and Prostate-related Mitogenic and Oncogenic Functions. Urology, 2000, 55:800-806.
5Gruber G, Schwarzmeier J, Shehata M, et al. Basic fibroblast growth factor is expressed by CD19/CD11cpositive cells in hairy cell leukemia. Blood, 1999, 94:1077-1085.
6Perez-Atayde A R, Sallan S E, Te drow U, et al.Spectrum of tumor angiogenesis in the bone marrow of children with acute lymphoblastic leukemia. Am J Pathol, 1997, 150:815-821.
